Live from the NIH registry
Studies recruiting near St. Louis right now
Top 25 of 1,492 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mercy Infusion Center - Chippewa — St Louis, Missouri (2.6 mi)
· Sponsor: SWOG Cancer Research Network
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
St. Louis Children's Hospital — St Louis, Missouri (2.6 mi)
· Sponsor: Nationwide Children's Hospital
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: National Cancer Institute (NCI)
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
St. Louis VA Medical Center John Cochran Division, St. Louis, MO — St Louis, Missouri (2.6 mi)
· Sponsor: VA Office of Research and Development
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Lung Cancer, Cancer of the Lung
N/A
Observational 279 participants sought
Barnes-Jewish Hospital West County — Creve Coeur, Missouri (9.7 mi)
· Sponsor: Washington University School of Medicine
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Washington University School of Medicine- Siteman Cancer Center — St Louis, Missouri (2.6 mi)
· Sponsor: Relay Therapeutics, Inc.
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
Joint Arthroplasty, Shoulder
N/A
Interventional 60 participants sought
Saint Louis University — St Louis, Missouri (2.6 mi)
· Sponsor: St. Louis University
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: RAI Services Company
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 226 participants sought
Research Site — St Louis, Missouri (2.6 mi)
· Sponsor: AstraZeneca
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
Washington University in St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: Tr1X, Inc.
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
Missouri Baptist — St Louis, Missouri (2.6 mi)
· Sponsor: NSABP Foundation Inc
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma (EHE)
Phase 2
Interventional 41 participants sought
Washington University St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: Sarcoma Alliance for Research through Collaboration
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Rheumatoid Arthritis, Systemic Lupus Erythematosus
Phase 1
Interventional 48 participants sought
Research Site — St Louis, Missouri (2.6 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
Washington University/Siteman Cancer Center — St Louis, Missouri (2.6 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — St Louis, Missouri (2.6 mi)
· Sponsor: Alkermes, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Midwest Vision Research Foundation — Chesterfield, Missouri (18.0 mi)
· Sponsor: Genentech, Inc.
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — St Louis, Missouri (2.6 mi)
· Sponsor: Daiichi Sankyo
SGLT2 Inhibitors in Geographic Atrophy
Retinal Degeneration, Retinal Diseases
Phase 2
Interventional 70 participants sought
Washington University — St Louis, Missouri (2.6 mi)
· Sponsor: Washington University School of Medicine
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Barnes Jewish Hospital — St Louis, Missouri (2.6 mi)
· Sponsor: Joseph Broderick, MD
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Solid Tumors, Sarcomas
Phase 1
Interventional 180 participants sought
Zai Lab Site 02005 — St Louis, Missouri (2.6 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
Surgical Wound Infection, Traumatic Wound Infection
Phase 1
Interventional 44 participants sought
Washington University in St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: Macro Biologics, Inc.
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Neurotrophic Keratitis
Phase 2
Interventional 54 participants sought
Ophthalmology Associates — St Louis, Missouri (2.6 mi)
· Sponsor: TearSolutions, Inc.